Medplus Health Services Limited
All news and filings related to Medplus Health Services Limited.
View all news & filings- Low impact
Medplus Board Comments on Non-Compliance Regarding Independent Director Appointment
Medplus Board addressed non-compliance regarding its Independent Director, Mr. Ajit Pandurang Rangnekar, who exceeded 75 years of age. The Board cited a bona fide interpretational difference, noting shareholder approval was obtained on August 17, 2026. Management is directed to strengthen governance processes.
Read the summary - Medium impact
Medplus Health to acquire 0.01% residual stake in Optival Health Solutions, making it wholly owned subsidiary
Medplus Health Services Limited will acquire the remaining 0.01% stake in Optival Health Solutions Private Limited for ₹1.10 crore, making it a wholly owned subsidiary. Optival Health Solutions reported a turnover of ₹6816.44 crore in FY 2025-26.
Read the summary - Low impact
Medplus Health Services Ltd. Submits 20th AGM Voting Results and Scrutinizer's Report
MedPlus Health Services Limited has submitted the voting results and Scrutinizer's Report for its 20th AGM held on August 17, 2026. All six resolutions were approved by the members. The reports will be available on the company and stock exchange websites.
Read the summary - Low impact
Medplus Health Services Holds 20th AGM on Aug 17, 2026
MedPlus Health Services Limited conducted its 20th AGM on August 17, 2026. The meeting included the adoption of audited standalone and consolidated financial statements for FY2026. Key decisions involved re-appointing existing directors and appointing new independent directors. Voting results will be announced post-submission to exchanges.
Read the summary - Low impact
Medplus Subsidiary Receives 3 Drug License Suspensions for One Day Each
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received three one-day drug license suspension orders for stores in Karnataka. The orders were received on August 5, 2026, impacting stores in Vijayapura and Raichur. Potential revenue losses are estimated between ₹0.17 lacs and ₹0.24 lacs.
Read the summary - Low impact
Medplus Subsidiary's Drug License Suspended for 2 Days in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, had a store's drug license suspended for two days in Karnataka. The suspension was ordered by the Drugs Control Administration, Raichur Circle. A potential revenue loss of ₹0.71 lacs is anticipated.
Read the summary - Low impact
Medplus Subsidiary's Telangana Store Drug License Suspended for 5 Days
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has had a drug license for a store in Telangana suspended for five days. The suspension, effective July 30, 2026, is expected to result in a revenue loss of ₹2.34 lacs.
Read the summary - Low impact
Medplus Subsidiary Receives 2-Day Drug License Suspension in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received a two-day suspension order for a drug license of a store in Bijapur, Karnataka. The order was received on July 25, 2026, and is expected to result in a potential revenue loss of ₹0.29 lakh.
Read the summary - Medium impact
MedPlus Health Services Q1 FY27 Earnings Call Transcript Released
MedPlus Health Services released its Q1 FY27 earnings call transcript. The company added a net of 146 stores, reaching 5,476. Consolidated revenue was ₹1879.6 crore with EBITDA at ₹65.1 crore. Capex proposals for food park and wellness facilities are on hold due to market feedback. Private label sales were 20% of revenue.
Read the summary - Low impact
Medplus Health Services Announces Newspaper Publication for 20th AGM Notice
Medplus Health Services Limited has published a newspaper notice regarding the dispatch of its 20th Annual General Meeting (AGM) notice. The publication was made on July 24, 2026, in 'Financial Express' and 'Nava Telangana'. Details will also be available on company and exchange websites.
Read the summary - Low impact
Medplus Subsidiary Faces Drug License Suspensions in Karnataka, Potential Revenue Loss of ₹2.4 Lakhs
Medplus subsidiary, Optival Health Solutions, received three drug license suspension orders in Karnataka for stores in Gulbarga and Bangalore. The suspensions are for two days each and are expected to cause a total revenue loss of approximately ₹2.4 lakhs. The actions are based on alleged violations of the Drugs and Cosmetics Act.
Read the summary - Low impact
Medplus Health Services Releases Business Responsibility and Sustainability Report for FY 2025-26
Medplus Health Services Limited has released its Business Responsibility and Sustainability Report for FY 2025-26. The report covers the company's ESG commitments, ethical practices, and stakeholder engagement. It details initiatives on employee well-being, product safety, and responsible supply chains, forming part of the Annual Report.
Read the summary - Medium impact
Medplus Health Services Announces 20th AGM on Aug 17, 2026, to Appoint New Directors and MD & CEO
Medplus Health Services will hold its 20th AGM on August 17, 2026. Key agendas include approving FY26 financial statements and appointing Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar as Independent Directors. Mr. Gangadi Madhukar Reddy is proposed for re-appointment as MD & CEO for five years.
Read the summary - Medium impact
Medplus Health Services Keeps CAPEX Plans in Abeyance
MedPlus Health Services Limited has decided to keep its CAPEX plans in abeyance. The board reviewed the business structure and market outlook, leading to the decision to pause the setup of a Food Park by Optival Health Solutions and a Concierge Health & Wellness Facility. The company expects no adverse impact on operations.
Read the summary - Low impact
Medplus Health Services Withdraws Inadvertent Investor Presentation Filing
Medplus Health Services inadvertently filed an investor presentation with an incorrect attachment on July 21, 2026. The company has requested this filing be ignored and has since submitted the correct presentation to BSE and NSE.
Read the summary - Low impact
Medplus Health Services Releases Audio Recording of Q1 FY26 Earnings Call
MedPlus Health Services has released the audio recording of its earnings call held on July 22, 2026, to discuss Q1 FY26 results. The recording is available on the company's website and stock exchange portals.
Read the summary - Low impact
Medplus Health Services Announces 20th AGM on August 17, 2026
MedPlus Health Services Limited will hold its 20th Annual General Meeting on August 17, 2026. The meeting will be conducted via Video Conferencing/Other Audio Visual Means.
Read the summary - Low impact
Medplus Health Services Submits Newspaper Publication of Q1 FY27 Financial Results
Medplus Health Services Limited published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were published on July 22, 2026, in the Financial Express and Nava Telangana newspapers.
Read the summary - Medium impact
Medplus Subsidiary Receives Three Drug License Suspensions in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received three drug license suspension orders in Karnataka. Two stores faced two-day suspensions with potential revenue losses of ₹0.49 lacs and ₹0.42 lacs, while another store received a one-day suspension with a potential loss of ₹0.12 lacs.
Read the summary - Medium impact
Medplus Health Q1 FY27 Revenue at ₹18,796m, Up 21.8% YoY
Medplus Health reported Q1 FY27 revenue of ₹18,796 million, up 21.8% YoY. Gross margin was ₹4,603 million (24.5% GM%). The company added 146 net stores, reaching a total of 5,476. Pharmacy Operating EBITDA was ₹588 million, and Company Operating EBITDA was ₹651 million. Operating Cash Flow was ₹1,252 million.
Read the summary - Medium impact
Medplus Health Q1 FY27 Revenue Grows 21.8% to ₹18,796 Million; EBITDA Declines
Medplus Health Services reported Q1 FY27 revenue of ₹18,796 million, a 21.8% YoY increase. The company added 146 new stores. However, Operating EBITDA decreased by 10.6% YoY to ₹651 million, and Operating EBITDA margin fell to 3.5%. Diagnostics revenue grew 22.4% YoY.
Read the summary - Low impact
Medplus Health Services Appoints Shrenik Soni as Company Secretary & Compliance Officer
Medplus Health Services appointed Shrenik Soni as Company Secretary and Compliance Officer effective July 21, 2026. Soni, an ICSI Fellow and MBA holder, has over 9 years of experience in corporate governance and compliance.
Read the summary - Medium impact
Medplus Approves Financial Results, Two New CAPEX Plans, and Appoints New Company Secretary
Medplus Health Services Limited approved its Q1 FY27 unaudited financial results. The company also approved CAPEX plans of ₹400 million for a food park and ₹1150 million for a wellness facility. Mr. Shrenik Soni was appointed as Company Secretary and Compliance Officer, effective July 21, 2026.
Read the summary - Low impact
Medplus Subsidiary Receives 2-Day Drug License Suspension in Karnataka
Medplus' subsidiary, Optival Health Solutions, received a two-day suspension order for a drug license for a store in Karnataka. The order was received on July 18, 2026, and is expected to result in a potential revenue loss of ₹0.53 lakh.
Read the summary - Low impact
Medplus Subsidiary Drug License Suspended for 5 Days in Maharashtra
Medplus's subsidiary, Optival Health Solutions Private Limited, has had its drug license suspended for five days for a store in Nashik, Maharashtra. The suspension, effective July 4, 2026, is due to alleged violations of the Drugs and Cosmetics Act. The company anticipates a revenue loss of ₹0.75 lacs.
Read the summary - Low impact
Medplus Subsidiary Receives 3-Day Drug License Suspension in Bangalore; ₹5.13 Lakh Revenue Impact
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received a three-day suspension order for a drug license of a store in Bangalore. The suspension, effective from July 01, 2026, is expected to result in a potential revenue loss of ₹5.13 lakhs.
Read the summary - Medium impact
Medplus Subsidiary Receives Three Drug License Suspension Orders in Karnataka and Andhra Pradesh
Medplus subsidiary, Optival Health Solutions, received three drug license suspension orders for stores in Karnataka and Andhra Pradesh. The suspensions range from one to three days, with potential revenue losses of ₹0.22 lacs, ₹0.60 lacs, and ₹0.76 lacs.
Read the summary - Low impact
Medplus Subsidiary Receives One-Day Drug License Suspension Order in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received a one-day drug license suspension for a store in Karnataka. The suspension, effective June 24, 2026, is expected to result in a potential revenue loss of ₹0.46 lacs.
Read the summary - Low impact
Medplus Subsidiary's Maharashtra Store Drug License Suspended for 10 Days
Medplus Health Services Limited's subsidiary, Optival Health Solutions, has had its Maharashtra store's drug license suspended for 10 days. The suspension, effective June 20, 2026, is expected to cause a potential revenue loss of ₹2.68 lacs.
Read the summary - Low impact
Medplus Subsidiary's Drug License Suspended for 3 Days in Telangana
Medplus Health Services' subsidiary, Optival Health Solutions, had a drug license for a Telangana store suspended for three days. The suspension, effective from June 19, 2026, is expected to result in a revenue loss of ₹0.78 lakh.
Read the summary - Low impact
Medplus Subsidiary Receives One-Day Drug License Suspension in Telangana
Medplus's subsidiary, Optival Health Solutions, received a one-day suspension order for a drug license of a store in Telangana. The suspension, effective June 18, 2026, is due to alleged violations of the Drugs and Cosmetics Act. The potential revenue loss is estimated at ₹0.47 lacs.
Read the summary - Low impact
Medplus Health Services: Independent Directors Madhavan Ganesan & Murali Sivaraman Cease Tenure
Mr. Madhavan Ganesan and Mr. Murali Sivaraman have completed their first term as Non-Executive Independent Directors at Medplus Health Services Limited. They cease to be directors effective June 10, 2026. The company acknowledged their contributions.
Read the summary - Low impact
Medplus Subsidiary's Drug License Suspended for 2 Days in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, had a store's drug license suspended for two days in Karnataka. The suspension, effective June 9, 2026, is due to alleged violation of the Drugs and Cosmetics Act. A potential revenue loss of ₹1.48 lacs is anticipated.
Read the summary - Low impact
Medplus Subsidiary Receives One-Day Drug License Suspension in Telangana
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received a one-day suspension for a drug license in Telangana. The order was issued by the Drugs Control Administration on June 02, 2026, citing a violation of the Drugs and Cosmetics Act. A potential revenue loss of ₹0.80 lacs is anticipated.
Read the summary - Low impact
Medplus Health Services Files Disclosure Under SEBI Takeover Regulations for Promoters
MedPlus Health Services Limited filed a disclosure under SEBI Takeover Regulations for Promoters Gangadi Madhukar Reddy, Agilemed Investments Private Limited, and Lone Furrow Investments Private Limited. The filing covers the period ending March 31, 2026. The disclosure will be available on company and exchange websites.
Read the summary - Medium impact
Medplus Subsidiary Optival Receives Two Drug License Suspensions
Medplus Health Services Limited's subsidiary, Optival Health Solutions, received two drug license suspension orders. One store in Nareducharla, Telangana, faces a five-day suspension with an estimated ₹0.85 lacs revenue loss. Another store in Laxmi Nagar Colony, Telangana, is suspended for two days with an estimated ₹0.18 lacs revenue loss.
Read the summary - Medium impact
Medplus Subsidiary Receives Three Drug License Suspension Orders
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received three drug license suspension orders for stores in Telangana and Karnataka. The suspensions range from one to three days, impacting potential revenue by ₹1.35 lacs, ₹1.49 lacs, and ₹0.65 lacs, respectively. The orders were received on May 27, 2026.
Read the summary - Medium impact
MedPlus Health Services Releases Q4 FY26 Earnings Call Transcript
MedPlus Health Services released its Q4 FY26 earnings call transcript on May 26, 2026. The company plans to open 800 net new stores in FY27. Consolidated revenue was ₹18,644 million (1864.4 crore) with operating EBITDA at ₹1,076 million (107.6 crore). Pharmacy revenue grew 23.4% YoY. The company aims to maintain its private label sales growth trajectory.
Read the summary - Low impact
Medplus Health: Subsidiary Optival Receives Drug License Suspension Orders, Potential ₹2.52 Lakh Revenue Loss
Medplus Health Services' subsidiary, Optival Health Solutions, received two Drug License suspension orders in Karnataka on 22 May 2026. The first, for a store in Madikeri, involves a two-day suspension with a potential revenue loss of ₹0.54 lakh. The second, for a store in Nagarabhavi, is a three-day suspension, potentially losing ₹1.98 lakh in revenue.
Read the summary - Low impact
Medplus Health Services Limited Files Audited Financial Results for Q4FY26
Medplus Health Services Limited's Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The results were published in Financial Express and Nava Telangana on May 22, 2026, and will be available on company and exchange websites.
Read the summary - Low impact
Medplus Health Services announces participation in Trinity India Conference on 28 May 2026
Medplus Health Services announced that Key Managerial Personnel will attend the Trinity India Conference in Mumbai on 28 May 2026 at 10:00 AM. The meeting will be physical. No Unpublished Price Sensitive Information will be disclosed during the meet. The schedule may change due to unforeseen circumstances.
Read the summary - Low impact
Medplus Health Services: Audio Recording of Q4FY26 Earnings Call on 21 May 2026
Medplus Health Services submitted the audio recording of its earnings call held on 21 May 2026 at 16:00 Hrs (IST) to discuss the financial results for the quarter and financial year ended 31 March 2026. The audio recording is available on the company's website and will also be accessible on the websites of BSE and NSE.
Read the summary - Low impact
Medplus Subsidiary Receives Drug License Suspension Orders for Two Stores
Medplus Health Services Limited's subsidiary, Optival Health Solutions, received drug license suspension orders for two stores. One store in Telangana faces a two-day suspension with a potential revenue loss of ₹0.18 lacs. Another store in Karnataka faces a five-day suspension, leading to a potential revenue loss of ₹4.85 lacs.
Read the summary - Low impact
Medplus Health Services Announces Resignation of Company Secretary & Compliance Officer
Mr. Manoj Kumar Srivastava has resigned as Company Secretary and Compliance Officer of Medplus Health Services Limited, effective May 20, 2026. The resignation is to pursue other career opportunities. The Board accepted his resignation on May 20, 2026.
Read the summary - Medium impact
Medplus Health Services Q4 FY26 Revenue Jumps 23.5% YoY to ₹18,644m
MedPlus Health Services reported Q4 FY2026 revenue of ₹18,644 million, up 23.5% YoY. Gross Margin was ₹4,934 million (26.5%). The company added 147 net stores in Q4, reaching 5,330 total. Pharmacy Operating EBITDA was ₹1,022 million. For FY2026, revenue grew 12.3% to ₹68,925 million.
Read the summary - Medium impact
Medplus Appoints Ajit Rangnekar, Mohankrishna Reddy as Independent Directors; Reappoints Gangadi Reddy as MD
Medplus Health Services Limited appointed Mr. Ajit Pandurang Rangnekar and Mr. Mohankrishna Reddy Arvabumi as Non-Executive Independent Directors effective May 20, 2026. The company also re-appointed Mr. Gangadi Madhukar Reddy as Managing Director for a five-year term starting August 03, 2026. Both appointments are subject to shareholder approval.
Read the summary - Medium impact
Medplus Appoints Two Independent Directors, Reappoints MD
MedPlus Health Services Limited appointed Mr. Ajit Pandurang Rangnekar and Mr. Mohankrishna Reddy Arvabumi as Non-Executive Independent Directors effective May 20, 2026. The company also reappointed Mr. Gangadi Madhukar Reddy as Managing Director for five years from August 03, 2026. All appointments are subject to member approval.
Read the summary - Low impact
Medplus Health Services Allots 82,419 Equity Shares Under ESOP 2021 on 20 May 2026
Medplus Health Services allotted 82,419 equity shares under ESOP 2021 on May 20, 2026. The face value is ₹2 each. Consequently, the paid-up share capital increased from ₹24,01,09,284 to ₹24,02,74,122. Shares were issued to eligible employees. Exercise prices were ₹628, ₹541.98, and ₹232 per share for different tranches.
Read the summary - Medium impact
Medplus Health Services Approves Audited Results, AGM on August 17, 2026
Medplus Health Services' board approved audited financial results for the year ended March 31, 2026, with revenue from operations at ₹18,643.85 million and PAT of ₹639.73 million. Ajit Pandurang Rangnekar and Mohankrishna Reddy Arvabumi were appointed as Additional Non-Executive Independent Directors effective May 20, 2026. Gangadi Madhukar Reddy was re-appointed as Managing Director from August 03, 2026. The 20th AGM is scheduled for August 17, 2026.
Read the summary - Low impact
Medplus Subsidiary Drug License Suspended for 3 Days in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, had a drug license for a store in Karnataka suspended for three days. The suspension, effective from May 14, 2026, is expected to result in a revenue loss of ₹1.34 lakh.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio